Retraction of: Scientific Reports 10.1038/srep42021, published online 10 February 2017
The Editors have retracted this Article.
After publication of this Article it was brought to the Editors’ attention that some of the data appear to overlap with data in other articles from the same author group, where the data is partially attributed to different samples. Specifically:
In Figure 3B the “vehicle + 50% HA” group appears to overlap with data in Figure 8 published in1;
In Figure 3B the “oxaliplatin + 50% HA” group appears to overlap with data in Figure 4a published in2;
In Figure 3C the “vehicle + 50% HA” group appears to overlap with data in Figure 4 published in3;
In Figure 4A the “vehicle + 50% HA” group appears to overlap with data in Figure 7d “vehicle + vehicle cg1” group published in2;
In Figure 4A the “vehicle + vehicle” group appears to overlap with data in Figure 7d “vehicle + vehicle M1” group published in2.
The Editors reached out to the Authors to request raw data. The Authors were unable to provide the data and the concerns remain unresolved. The Editors therefore no longer have confidence in the results presented in this Article.
All Authors agree with the retraction of the Article.
References
- 1.Di Cesare ML, Pacini A, Micheli L, Zanardelli M, Ghelardini L. Glial role in oxaliplatin-induced neuropathic pain. Exp. Neurol. 2014 doi: 10.1016/j.expneurol.2014.06.016. [DOI] [PubMed] [Google Scholar]
- 2.Pacini A, Micheli L, Maresca M, Branca JJV, McIntosh JM, Ghelardini C, Di Cesare Mannelli L. The α9α10 nicotinic receptor antagonist α-conotoxin RgIA prevents neuropathic pain induced by oxaliplatin treatment. Exp. Neurol. 2016 doi: 10.1016/j.expneurol.2016.04.022. [DOI] [PubMed] [Google Scholar]
- 3.Di Cesare ML, Pacini A, Bonaccini L, Zanardelli M, Mello T, Ghelardini C. Morphologic features and glial activation in rat oxaliplatin-dependent neuropathic pain. TJ. Pain. 2012 doi: 10.1016/j.jpain.2013.08.002. [DOI] [PubMed] [Google Scholar]